Study: 60% of CBD Sleep Products Are Mislabeled
Thu / Apr 28th
The majority of CBD products marketed for sleep are inaccurately labeled for CBD, CBN, or melatonin content, according to a recent study by Leafreport.
The latest news about scientific research related to cannabis. To read academic medical studies that have been conducted in the past, check out our medical cannabis resources page. For more cannabis news and research updates, subscribe to our daily newsletter!
Thu / Apr 28th
The majority of CBD products marketed for sleep are inaccurately labeled for CBD, CBN, or melatonin content, according to a recent study by Leafreport.
Thu / Apr 28th
Kentucky Gov. Andy Beshear (D) signed legislation this week to create a cannabis research center at the University of Kentucky.
Wed / Apr 20th
Legalizing adult-use cannabis lowers the demand for prescription drugs through state Medicaid programs, according to a recent study.
Thu / Apr 7th
A recent study by the Kansas State University College of Veterinary Medicine found that feeding cattle CBDA-rich hemp decreased the animals’ stress hormone cortisol and inflammation biomarkers.
Tue / Apr 5th
The U.S. House approved a bipartisan cannabis research bill this week that would expand research possibilities and let researchers study cannabis products acquired through state-legal markets.
Fri / Mar 18th
Researchers at Rensselaer Polytechnic Institute have developed hemp-based rebar for concrete construction projects that should both last longer and carry a smaller carbon footprint than steel rebar.
Tue / Mar 8th
A recent poll found that less than half of U.S. parents know much about the use of CBD products with regard to children and most have never tried CBD themselves.
Thu / Feb 17th
A recent survey found that cannabis consumers have more sex than non-consumers. Additionally, 65% of sexually active cannabis consumers agree that the plant enhances their sex life and helps them get in the mood for sex.
Thu / Feb 10th
A new study published in the American Journal of Preventive Medicine found that two in five drivers who reported using alcohol and cannabis in the past year drove under the influence.
Tue / Feb 8th
A new study has found that at least half of participants who smoke cannabis had a significantly diminished ability to drive compared to subjects who smoked a placebo cigarette.
Mon / Feb 7th
Flora Growth Corp. submitted an application to Colombian regulators for researching whether a cannabinoid-based product can help prevent COVID-19 infections.
Fri / Jan 21st
The University of Mississippi launched the National Center for Cannabis Research and Education to conduct scientific research and aid in policymaking and legalization-related outreach.
Wed / Jan 19th
According to a recent survey, respondents between the ages of 18 to 30 who use cannabis and alcohol have better sexual functions and orgasms than those that don’t consume either.
Thu / Jan 13th
A new survey found 88.8% of patients with a skin condition would try a medical cannabis-based treatment.
Tue / Jan 11th
Researchers at the University of Mississippi have been awarded $1.37 million to study if cannabis can help manage HIV-related pain in patients.
Mon / Jan 10th
The biotech pharma firm ANANDA Scientific Inc. announced it has received FDA approval to study a CBD-based drug as a treatment for opioid-use disorder.
Fri / Jan 7th
Groff North America Hemplex and BRC, two cannabis cultivation firms, have harvested federally sanctioned cannabis for research purposes, ending a 50-year monopoly by the University of Mississippi.
Mon / Jan 3rd
A recent study found significant improvement in autism symptoms following treatment with THC-rich cannabis oil.
Fri / Dec 31st
A recent study found that cannabis decriminalization policies have helped to reduce the racial disparity in cannabis possession arrests.
Wed / Dec 22nd
A set of GOP companion bills in the House and Senate seeking to curb illegal fentanyl sales would also streamline the research of cannabis, psychedelics, and other Schedule I substances.
Tue / Dec 7th
Researchers at the University of Sydney in Australia have found that blood and oral fluid THC concentrations are weak indicators of cannabis-induced impairment.
Mon / Dec 6th
A new study found that psilocybin may be able to reverse alcohol brain damage, reduce alcohol-addictive behavior, and reduce relapse rates.
Fri / Nov 5th
NORML released an updated and revised version of “Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000-2021.” Proceeds from the book will be used to fund NORML’s advocacy efforts.
Mon / Nov 1st
A recent survey found 65% of patients were able to reduce or eliminate taking at least one prescription medication after obtaining their medical cannabis registration.
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.